Medical/Pharmaceuticals Global News & Press Release Distribution

Medical/Pharmaceuticals

All
APAC

Caliway Announces CBL-514 Phase 2 Study Topline Results for Dercum's Disease, Showing 64.5% of Lipomas with Complete Clearance or Dimensions Reduction of Over 50% and Reduced Pain by 4.7

- CBL-0201DD Phase 2 study met the primary and all secondary endpoints. - 64.5% of painful lipomas showed complete clearance or dimensions reduction of more than 50% after CBL-514 treatments. - 54.8% of painful lipomas showed complete clearance or dimension reduction of more th...

2023-09-13 13:42 2090

AIRS Medical Inc. receives MDSAP Certification, Paving the Way for Global Expansion

SEOUL, South Korea, Sept. 13, 2023 /PRNewswire/ -- AIRS Medical Inc., an AI-powered healthcare solution provider headquartered in Korea announces the attainment of MDSAP (Medical Device Single Audit Program) certification. This milestone achievement underscores AIRS Medical's commitment to qualit...

2023-09-13 12:44 2140

GemPharmatech's Board Appoints Brandy Wilkinson, Ph.D. as its New Chief Executive Officer of GemPharmatech LLC.

SAN DIEGO, Sept. 12, 2023 /PRNewswire/ -- GemPharmatech LLC., a leading contract research organization, announced today that its Board of Directors has appointed Dr.Brandy Wilkinson as the Chief Executive Officer of its subsidiary inthe United States, effective September 12, 2023.

2023-09-13 00:00 2797

GemPharmatech's Board Appoints Brandy Wilkinson, Ph.D. as its New Chief Executive Officer of GemPharmatech LLC.

Standigm's "Green Ribbon Campaign" to support Mitochondria Disease Awareness Week

SEOUL, South Korea, Sept. 12, 2023 /PRNewswire/ -- On September 5th, 2023 Standigm, a company using artificial intelligence (AI) technology for drug discovery and development launched, the "Green Ribbon Campaign," event to support the upcoming Mitochondrial Disease Awareness Week scheduled for Se...

2023-09-12 21:00 2282

Datasea Announces Pricing of $2.0 Million Underwritten Public Offering

BEIJING, Sept. 12, 2023 /PRNewswire/ -- Datasea Inc., (NASDAQ: DTSS) ("Datasea" or the "Company"), aNevada incorporated digital technology corporation engaged in converging and innovative business segments for intelligent acoustics and 5G messaging technology inChina, today announced the pricing ...

2023-09-12 20:30 5299

Henlius Expands Collaboration with KGbio to Develop, Commercialize and Supply Henlius' novel anti-PD-1 mAb HANSIZHUANG in MENA

* HANSIZHUANG's coverage footprint includes 22 emerging market countries acrossSoutheast Asia and MENA – * KGbio to develop and commercialise HANSIZHUANG in 12 MENA countries; Henlius to receiveUS$7 million upfront payment plus royalties and up to US$8 million in regulatory milestone payments...

2023-09-12 19:24 2280

Genesis MedTech introduces China's first domestic brand of NPMA-approved antibacterial sutures

SINGAPORE, Sept. 11, 2023 /PRNewswire/ -- Genesis MedTech, a leading medical device company, today announced that its absorbable sutures with antibacterial protection have successfully obtained approval from theChina's National Medical Products Administration (NMPA) for market release. The newly...

2023-09-12 07:00 2628

Study Validates Lunit AI as a Game-Changer, Poised to Replace One Human Reader in Breast Cancer Screening

- Lunit's collaborative study supports AI as a viable alternative to one human reader inEurope's double reading system - published in The Lancet Digital Health SEOUL, South Korea, Sept. 11, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnosti...

2023-09-11 21:00 2904

Study Validates Lunit AI as a Game-Changer, Poised to Replace One Human Reader in Breast Cancer Screening

Norgine Strengthens Senior Leadership with the Appointment of Saulo Martiniano as Chief Operating Officer

AMSTERDAM, Sept. 11, 2023 /PRNewswire/ -- Norgine, a leading European specialist pharmaceutical company dedicated to improving the lives of patients, is pleased to announce the appointment ofSaulo Martiniano as its new Chief Operating Officer (COO). Saulo joins Norgine with a wealth of experience...

2023-09-11 15:00 2042

Norgine Strengthens Senior Leadership with the Appointment of Saulo Martiniano as Chief Operating Officer

Mabwell and WuXi XDC Sign Long-Term ADC Strategic Collaboration to Accelerate Global Layout of Innovative Biologics

SHANGHAI, Sept. 8, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, and WuXi XDC, a leading global CRDMO, joint announced that they have signed a LOI for long-term strategic collaboration on Mabwell's multiple ADC projects. Mabwell has...

2023-09-08 15:30 2271

World Orphan Drug Alliance Welcomes Specialised Therapeutics

* SEA's largest independent specialty pharma company Specialised Therapeutics (ST) has joined global pharma consortium committed to collaborating to provide new specialist medicines for rare diseases. * ST to represent WODA in Australia, New Zealand and across Southeast Asia (ANZSEA). * Wor...

2023-09-08 04:00 3950

United Imaging Confirms Installation of Country's First uMI Panorama™ at Huntsman Cancer Institute

The award-winning 12-year old manufacturer and widely-recognized leading cancer center agreed to install United Imaging's recently unveiled innovation. HOUSTON, Texas, Sept. 7, 2023 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, announced t...

2023-09-07 21:00 2175

SOAP Health and AESOP Technology Unite to Provide Advanced AI Solutions for Clinical Decision-Support and Medical Coding

SOAP Health's conversational AI for medical encounters, risk and symptom assessment, and documentation integrates with AESOP Technology's electronic medical record data analysis for clinical decision optimization, coding, and productivity. BOCA RATON, Fla., Sept. 7, 2023 /PRNewswire/ -- SOAP Hea...

2023-09-07 21:00 2944

Isotopia Issues a call to action to the radionuclide Therapy industry.

PETAH TIKVA, Israel, Sept. 6, 2023 /PRNewswire/ -- Isotopia Molecular Imaging is a global pharmaceutical company that develops, produces, and distributes therapeutic and diagnostic radioactive isotopes. "If you are in the Lu-177 field, don't miss this information." The Lu-177 radiopharmaceutical...

2023-09-06 20:40 1936

Health In Tech Introduces New Ancillary Products to Expand Healthcare Solutions

Expands Health Care offerings with Critical Illness, Accident, Dental, Vision, Term Life, and Gap coverage options. STUART, Fla., Sept. 6, 2023 /PRNewswire/ -- Health In Tech, an industry-leading insurtech company that delivers disruptive innovation and re-imagines self-funded health plans, is e...

2023-09-06 20:30 2314

Gracell Biotechnologies to Present Updated Clinical Data on BCMA/CD19 Dual-Targeting FasTCAR-T GC012F in Newly Diagnosed Multiple Myeloma at the 2023 International Myeloma Society Annual Meeting

SAN DIEGO, Calif., and SUZHOU and SHANGHAI, China, Sept. 6, 2023 /PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated to developing innovative and highly efficacious cell therapies for the treatment o...

2023-09-06 20:00 2415

Gloria Biosciences Announces Zimberelimab Approved in China for the Treatment of Recurrent or Metastatic Cervical Cancer

* The first and only anti-PD-1 antibody approved for treating cervical cancer inChina * ORR of 27.8%, mPFS of 3.7m, and mOS of 16.8m achieved as monotherapy with best-in-class potential * A Phase 3 trial (VICT-004) of zimberelimab in combination with platinum-based chemotherapy +/- bevacizu...

2023-09-06 19:00 2134

CANbridge to Participate in Two Investor Conferences in September

BEIJING and BURLINGTON, Mass., Sept. 6, 2023 /PRNewswire/ -- CANbridge Pharmaceuticals Inc. (HKEX:1228), a global biopharmaceutical company, with a foundation inChina, committed to the research, development and commercialization of transformative rare disease and rare oncology therapies, today a...

2023-09-06 16:06 2348

Exosomes functionally deliver siRNAs in vivo to repress tumor growth

SUZHOU, China, Sept. 5, 2023 /PRNewswire/ -- VesiCURE Therapeutics Co. Ltd., a biotechnology company located in Suzhou,China, recently released a preprint on BioRxiv titled "Harnessing extracellular vesicles for efficient siRNA delivery in vitro and in vivo" (doi:https://doi.org/10.1101/2023.0...

2023-09-05 21:20 2526

David Topper Joined Inmagene as CFO

SAN DIEGO, Sept. 5, 2023 /PRNewswire/ -- Inmagene Biopharmaceuticals ("Inmagene"), a clinical stage biotechnology company developing innovative and differentiated therapies for immunological and inflammatory diseases, today announced the appointment ofDavid Topper as Chief Financial Officer (C...

2023-09-05 20:00 2531

1 ... 162 163 164165166 167 168 ... 262